Ross Hanson

Ross Hanson has a diverse work experience spanning over many years. Ross has held various roles in financial planning and analysis, business planning, and financial operations.

Starting from their most recent position, Ross worked as the Senior Director of Financial Planning & Analysis at Dyne Therapeutics since May 2023. Prior to that, they held the same role at Laronde from January 2022 to March 2023.

Before joining Dyne Therapeutics and Laronde, Ross worked at Deciphera Pharmaceuticals as the Director of Clinical Business Planning from January 2019 to December 2021. During their time at Deciphera Pharmaceuticals, they also served as a Financial Planning Consultant from June 2018 to December 2018.

Ross gained valuable experience in financial planning and consulting while completing their MBA at the Babson F.W. Olin Graduate School of Business from 2016 to 2017.

Prior to their MBA, Ross served as the Director of Financial Operations at Frenova Renal Research from 2013 to 2015. Ross then joined Biogen, where they held different roles, including Associate Director of Clinical Business Operations from January 2012 to September 2012, Senior Manager of Business Planning & Analysis from October 2010 to December 2011, and Manager of Business Planning & Analysis from March 2008 to September 2010.

Ross started their career as a Senior Financial Analyst at Boston Scientific in the Corporate R&D division from March 2007 to March 2008. Ross then worked as a Financial Analyst in R&D at Neurocrine Biosciences from August 2005 to September 2006.

Ross's earliest work experience was as a Financial Analyst in the FMC Extracorporeal Alliance division at Fresenius Medical Care North America from August 2003 to August 2005.

Throughout their career, Ross has developed expertise in financial planning and analysis, business planning, and financial operations in the pharmaceutical and medical research industries.

Ross Hanson has a Bachelor's degree in Economics from Emory University. Ross also holds an MBA with a focus on Healthcare/Life Sciences from the Babson F.W. Olin Graduate School of Business. No specific start or end years are provided for both degrees.